NCT03960112Completed
Multicentric Evaluation of the True Negative Predictive Value of Multiparametric MRI for the Detection of Prostate Cancer Using Cystoprostatectomy Specimen as Reference
Source: ClinicalTrials.gov · Last updated 14 Oct 2026
Brief summary (registry, in English)
To evaluate the negative predictive value of mpMRI in the detection of prostate cancer using cystoprostatectomy specimen as the reference
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 12 (actual)
- First submitted
- 18 Sept 2018
- Start date
- 13 Jun 2023
- Primary completion date
- 23 Jun 2025
- Lead sponsor
- Institut Paoli-Calmettes
- Diseases
- Prostate cancer
- NCT number
- NCT03960112
What you commit to
- Study type: Interventional
- Participants enrolled: 12
- From 13 Jun 2023 to the primary completion date, 23 Jun 2025
- 5 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- diagnosis or previous treatment of prostate cancer
- Pelvic metallic implants such as hip prosthesis
Other illness
- allergy against MR contrast media
- Bladder cancer infiltrating the prostate (T4)
Lab values
- severe renal insufficiency (GFR \<30ml/min)
Other
- Patients scheduled for cystoprostatectomy with prostate capsule sparing
- Patients unable to provide informed consent
- Patients having a prostate biopsy \<6 month
Who the study is looking for
- age \>18 years
- male patient scheduled for cystoprostatectomy as treatment of muscle invasive bladder cancer (clinical T2-T3, any N) or high risk non-muscle invasive bladder cancer (pT1 or CIS)
- no known diagnosis of prostate cancer
- no contraindication to undergo multiparametric MRI
- Signed written informed consent prior to any screening procedures being performed
- Patient affiliated to the ''National security'' regimen or beneficiary of this regimen
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHRU Hopital Edouard Herriot Coordinator of this site? Confirm its status | Lyon | France | Unknown status |
| Institut Paoli-Calmettes Coordinator of this site? Confirm its status | Marseille | France | Unknown status |
| Hôpital Nord Coordinator of this site? Confirm its status | Marseille | France | Unknown status |
| Institut Mutualiste Montsouris Coordinator of this site? Confirm its status | Paris | France | Unknown status |
| CHU Saint-Etienne Coordinator of this site? Confirm its status | Saint-Etienne | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.